A Multi-Centered Randomized Trial Evaluating the Chronotherpaeutic Role of Melatonin
Learn More About This Topic: Chat with Us | Email Us
A Multi-Centered Randomized Trial Evaluating the Chronotherpaeutic Role of Melatonin in the Treatment of Stage III and IV Non-Small Cell Lung Carcinoma
Summary
This study tests whether Melatonin reduces the side effects of chemotherapy, and also if by adding melatonin to the patient's body, it is possible to recreate the biological rhythms of a healthy adult. This study is available to patients at Midwestern Regional Medical Center diagnosed with advanced non-small cell lung cancer who meet study eligibility requirements.
For More Information:
Please contact one of our Oncology Information Specialists at 1-800-615-3055 to learn more about this clinical trial. Oncology Information Specialists are available 24 hours a day, 7 days a week, 365 days a year.
